Precigen grants CCO RSUs and stock options

Precigen, Inc. reported that Chief Commercial Officer Phil Tennant received new equity awards.

Rhea-AI Filing Summary

Precigen, Inc. reported that Chief Commercial Officer Phil Tennant received new equity awards. On April 20, 2026, he was granted 115,000 restricted stock units, each representing the right to receive one share of Precigen common stock. He was also granted 385,000 stock options with an exercise price of $4.11 per share, expiring on April 20, 2036.

The options vest 25% on May 23, 2027 and then in equal monthly installments for three years. The RSUs vest 25% on May 23, 2027 and then in equal six-month installments for three years. After these grants, Tennant holds 115,000 RSUs and options covering 385,000 shares, all as direct ownership.

Insider Trade Summary

Grant/Award: 500,000 shares

Grant/Award 2 txns

Insider Tennant Phil

Role Chief Commercial Officer

Type	Security	Shares	Price	Value
Grant/Award	Option to Purchase Common Stock (Right to Buy)	385,000	$0.00	$0.00
Grant/Award	Restricted Stock Units	115,000	$0.00	$0.00

Holdings After Transaction: Option to Purchase Common Stock (Right to Buy) — 385,000 contracts (Direct); Restricted Stock Units — 115,000 contracts (Direct)

Footnotes (3)

1. F1. The options vest 25% on May 23, 2027 and in equal monthly installments for three years thereafter.
2. F2. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
3. F3. The RSUs vest 25% on May 23, 2027 and in equal six-month installments for three years thereafter.

Key Figures

RSU grant: 115,000 RSUs Option grant: 385,000 options Option exercise price: $4.11 per share +5 more

8 metrics

RSU grant 115,000 RSUs Granted April 20, 2026 to Chief Commercial Officer

Option grant 385,000 options Granted April 20, 2026, right to buy common stock

Option exercise price $4.11 per share Conversion or exercise price for 385,000 options

Option expiration April 20, 2036 Expiration date of stock options

RSU vesting start May 23, 2027 25% of RSUs vest, then semiannual vesting for three years

Option vesting start May 23, 2027 25% of options vest, then monthly vesting for three years

RSUs held after grant 115,000 RSUs Total restricted stock units following transaction

Options held after grant 385,000 options Total options following transaction

Key Terms

Restricted Stock Units, Option to Purchase Common Stock (Right to Buy), exercise price, vesting, +1 more

5 terms

Restricted Stock Units financial

"security_title": "Restricted Stock Units""

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Option to Purchase Common Stock (Right to Buy) financial

"security_title": "Option to Purchase Common Stock (Right to Buy)""

exercise price financial

"conversion_or_exercise_price": "4.1100""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting financial

"The options vest 25% on May 23, 2027 and in equal monthly installments"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

restricted stock unit ("RSU") financial

"Each restricted stock unit ("RSU") represents a contingent right"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did Precigen (PGEN) grant to its Chief Commercial Officer?

Precigen granted Chief Commercial Officer Phil Tennant 115,000 restricted stock units and 385,000 stock options. The RSUs convert into common shares upon vesting, while the options allow him to buy Precigen common stock at a fixed exercise price.

What is the exercise price and expiry of Phil Tennant’s new Precigen (PGEN) stock options?

Phil Tennant’s new stock options cover 385,000 shares at an exercise price of $4.11 per share. These options expire on April 20, 2036, giving him a long-dated opportunity to purchase Precigen common stock if vesting conditions are met.

How do the new Precigen (PGEN) restricted stock units for Phil Tennant vest?

The 115,000 RSUs granted to Phil Tennant vest 25% on May 23, 2027. The remaining RSUs then vest in equal six-month installments over the following three years, aligning long-term incentives with multi‑year company performance.

What is the vesting schedule for Phil Tennant’s new Precigen (PGEN) stock options?

The 385,000 stock options vest 25% on May 23, 2027. The remaining options then vest in equal monthly installments for three years, creating a gradual vesting pattern that extends across a multi‑year period of continued service.

Are Phil Tennant’s new Precigen (PGEN) equity awards direct or indirect holdings?

The filing shows Phil Tennant’s new RSUs and stock options as direct ownership. There are no footnotes indicating that these awards are held through separate entities, so they are attributed directly to him in the report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/22/2026 - 04:20 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tennant Phil

(Last) (First) (Middle)

20374 SENECA MEADOWS PARKWAY

(Street)

GERMANTOWN MARYLAND 20876

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PRECIGEN, INC. [ PGEN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Stock (Right to Buy)	$4.11	04/20/2026		A		385,000		(1)	04/20/2036	Common Stock	385,000	$0	385,000	D
Restricted Stock Units	(2)	04/20/2026		A		115,000		(3)	(3)	Common Stock	115,000	$0	115,000	D

Explanation of Responses:

1. The options vest 25% on May 23, 2027 and in equal monthly installments for three years thereafter.

2. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.

3. The RSUs vest 25% on May 23, 2027 and in equal six-month installments for three years thereafter.

	/s/ Phil Tennant, by Donald P. Lehr, as attorney-in-fact	04/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)